Maeshima Akito, Miya Masaaki, Mishima Keiichiro, Yamashita Shin, Kojima Itaru, Nojima Yoshihisa
Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine, Japan.
Endocr J. 2008 Mar;55(1):1-9. doi: 10.1507/endocrj.kr-113. Epub 2007 Sep 7.
The research described in this review suggests a novel and important role for activin A in the developmental and repair processes of the kidney (Table 1). The results obtained in these studies indicate that activin A is a negative regulator of kidney development and plays an essential part in kidney diseases, such as acute renal failure or renal fibrosis. It is also possible that activin A is a key player in the pathophysiological processes of other kidney diseases, such as congenital urogenital abnormalities, renal cystic disease and renal cell carcinoma. Activin A is thus a potential target for therapeutic interventions in kidney diseases. To address this issue, more detailed analysis on the regulation of activin production, modulation of activin activity and activin target genes is required.
本综述中描述的研究表明,激活素A在肾脏的发育和修复过程中具有新的重要作用(表1)。这些研究获得的结果表明,激活素A是肾脏发育的负调节因子,在诸如急性肾衰竭或肾纤维化等肾脏疾病中起重要作用。激活素A也有可能是其他肾脏疾病,如先天性泌尿生殖系统异常、肾囊性疾病和肾细胞癌的病理生理过程中的关键参与者。因此,激活素A是肾脏疾病治疗干预的潜在靶点。为解决这一问题,需要对激活素产生的调节、激活素活性的调节以及激活素靶基因进行更详细的分析。